Jan 13, 2021 / 03:00PM GMT
James Daniel Gordon - JPMorgan Chase & Co, Research Division - Senior Analyst
Good morning and good afternoon. I'm James Gordon, JPMorgan European pharma and biotech analyst. And today, it's my pleasure to introduce this Genmab presentation with CEO, Jan van de Winkel, as part of the JPMorgan Healthcare Conference. So today, we have a 20-minute presentation from Jan and then 20 minutes for questions. And then we'll also have CFO, Anthony Pagano, joining us as well. And you can immediately start registering your questions. (Operator Instructions) And then I'll be reading out those questions in the Q&A segment.
So with that said, I'd like to welcome Jan to the conference, and I'm looking forward to the presentation.
Jan G.J. van de Winkel - Genmab A/S-Co-Founder - President & CEO
Thank you, James. It's a pleasure to join you once again, albeit virtually, at the Annual JPMorgan Healthcare Conference as we kick off 2021. Slides from today's presentation will be available for download on
Genmab A/S at JPMorgan Healthcare Conference (Virtual) Transcript
Jan 13, 2021
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers